Offer - Urjas Oil for just ₹ 1 X
Jubira F 5 Tablet is a commercial drug that is prescribed in the form of Tablet. Other than this, Jubira F 5 Tablet has some other therapeutic uses, which have been discussed ahead.
The correct dosage of Jubira F 5 Tablet depends on the patient's age, gender, and medical history. Besides the medical condition it is advised for, the route of administration also plays an important role in determining the correct drug dosage. For detailed information on this, read through the dosage section.
Jubira F 5 Tablet also has some side effects, the most common being Nausea or vomiting, Headache, Constipation. Some other side effects of Jubira F 5 Tablet have been listed ahead. These side effects of Jubira F 5 Tablet are usually temporary and subside with the completion of treatment. Please speak with your doctor if these side effects worsen or persist for a longer duration.
Jubira F 5 Tablet's effect during pregnancy is Moderate and Moderate while nursing. Further, the section on Jubira F 5 Tablet related warnings talks about Jubira F 5 Tablet's effects on the liver, heart and kidney.
Jubira F 5 Tablet is contraindicated in people with pre-existing medical conditions like Diabetes as it can result in adverse effects.
Drug reaction of Jubira F 5 Tablet with other medicines has been reported. Refer to the list below for further details.
In addition to these precautions, you may also note that Jubira F 5 Tablet is not safe while driving, and is is not addictive in nature.
Jubira F 5 Tablet is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
13 - 18 years (Adolescent) |
|
2 - 12 years (Child) |
|
Adult |
|
Geriatric |
|
Is the use of Jubira F 5 Tablet safe for pregnant women?
Pregnant women may experience moderate side effects from Jubira F. It is best to stop taking Jubira F immediately and inform your doctor if you notice any discomfort.
Is the use of Jubira F 5 Tablet safe during breastfeeding?
Jubira F may lead to some side effects in breastfeeding women. If you witness any unusal symptoms after taking Jubira F, discontinue its use and call your doctor right away. Follow your doctor's advice regarding the use of Jubira F.
What is the effect of Jubira F 5 Tablet on the Kidneys?
Very few cases of side effects of Jubira F on kidney have been reported.
What is the effect of Jubira F 5 Tablet on the Liver?
Jubira F has very mild side effects on the liver.
What is the effect of Jubira F 5 Tablet on the Heart?
The heart can be affected by Jubira F. If you experience any unwanted effects of this drug, stop taking it and consult your doctor. You should restart the medicine only after medical advice.
If you are suffering from any of the following diseases, you should not take Jubira F 5 Tablet unless your doctor advises you to do so -
Is this Jubira F 5 Tablet habit forming or addictive?
Forming a habit of Jubira F 5 Tablet has not been reported.
Is it safe to drive or operate heavy machinery when consuming?
No, you should do not do anything that requires concentration and attention as the Jubira F 5 Tablet can make you feel drowsy.
Is it safe?
Jubira F 5 Tablet should be used only after doctor's advice.
Is it able to treat mental disorders?
No, Jubira F 5 Tablet cannot treat any kind of mental disorder.
Interaction between Food and Jubira F 5 Tablet
Due to a lack of research, nothing can be said about the consequences of taking Jubira F 5 Tablet together with food.
Interaction between Alcohol and Jubira F 5 Tablet
No research has been done on this till date. Therefore, it is not known what the effect of taking Jubira F 5 Tablet with alcohol will be.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Triglide (fenofibrate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 639-640
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 551-552
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Crestor (rosuvastatin calcium)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 636,637
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 646-650